A multivariate survival analysis only disclosed statistically significant correlations between the serum BRAT1-Ab levels and lymph node metastasis (P = 0.05), CRP level (P = 0.05), and tumor depth (P = 0.03). This evidence concerns the gene BRAT1 and metastatic malignant neoplasm in the lymph nodes.